MRP8/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8/14 and increased expression of adhesion molecules following renal transplantation.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 7533437)

Published in Transplant Proc on February 01, 1995

Authors

K Burkhardt1, A Bösnecker, G Hillebrand, G O Hofmann, H Schneeberger, G Burmeister, W Land, H J Gurland

Author Affiliations

1: Nephrology Department, Klinikum Grosshadern, University of Munich, Germany.

Articles by these authors

CC chemokine receptor 5 and renal-transplant survival. Lancet (2001) 2.82

Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet (2001) 2.76

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90

Combined report on regular dialysis and transplantation in Europe, VIII, 1977. Proc Eur Dial Transplant Assoc (1978) 1.85

Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int (1993) 1.80

Mortality and morbidity of reusing dialysers. A report by the registration committee of the European Dialysis and Transplant Association. Br Med J (1978) 1.70

The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation (1994) 1.69

Combined report on regular dialysis and transplantation of children in Europe, 1977. Proc Eur Dial Transplant Assoc (1978) 1.64

Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc Eur Dial Transplant Assoc (1977) 1.63

Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol (2004) 1.49

Valproate for epilepsy in renal transplant recipients receiving cyclosporine. Transplantation (1987) 1.42

Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol (1991) 1.42

[Peripartum cardiomyopathy: interdisciplinary challenge]. Anaesthesist (2013) 1.39

Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene. Am J Kidney Dis (2001) 1.38

Combined report on regular dialysis and transplantation in Europe, II, 1971. Proc Eur Dial Transplant Assoc (1972) 1.36

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33

New aspects in the emergency room management of critically injured patients: a multi-slice CT-oriented care algorithm. Injury (2007) 1.27

Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion (1995) 1.25

Clinical pancreatic transplantation using the prolamine duct occlusion technique--the Munich experience. Transplant Proc (1987) 1.16

Combined report on regular dialysis and transplantation in Europe, 3, 1972. Proc Eur Dial Transplant Assoc (1973) 1.15

Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest (1995) 1.12

Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection. Transplantation (1993) 1.11

Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int (2001) 1.10

Metabolic studies of type I diabetics after successful segmental pancreas and kidney transplantation. Transplant Proc (1990) 1.05

Prolamine solution to block pancreatic duct. Lancet (1979) 1.03

The myeloic related protein MRP8/14 (27E10 antigen)--usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest (1995) 1.03

Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF). Immunobiology (1986) 1.01

Effect of somatostatin analogue (SMS201-995) on cyclosporine levels. Transplantation (1987) 1.01

Immunohistochemical demonstration of migration inhibitory factor (MIF) in experimental allergic contact dermatitis. Clin Exp Immunol (1988) 0.99

Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc (1999) 0.99

A different clinical course of IDDM patients after simultaneous pancreas and kidney transplantation and kidney grafting alone. Transplant Proc (1990) 0.99

Long-term results in pancreatic transplantation with special emphasis on the use of prolamine. Diabetologia (1991) 0.96

Combined kidney/pancreas transplantation--poor long-term outcome of renal grafts. Transplant Proc (1987) 0.96

[Infectious bone diseases]. Pathologe (2011) 0.96

Incidence of fistulas following human pancreas transplantation--positive influence of reabsorption of pancreatic secretions by the peritoneum. Transplant Proc (1987) 0.93

Ulcer perforation in the grafted duodenal segment following pancreatic transplantation--a case report. Transplant Proc (1992) 0.93

Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood. Artif Organs (1993) 0.91

Strategies for the analysis of osteitic bone defects at the diaphysis of long bones. Strategies Trauma Limb Reconstr (2009) 0.91

Osteosynthetic reconstruction in a patient with Gardner-Diamond syndrome. J Trauma (1995) 0.91

Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation. Diabetes (1989) 0.91

LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood. Artif Organs (1997) 0.90

Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc (2001) 0.90

Importance of arterial blood supply to the femur and tibia for transplantation of vascularized femoral diaphyses and knee joints. World J Surg (1998) 0.90

Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol (1994) 0.89

Altered interleukin-1 production in patients undergoing hemodialysis. Nephron (1988) 0.89

Vascular complications in 1,200 kidney transplantations. Transplant Proc (1987) 0.89

Platelet-leukocyte aggregation during hemodialysis. Kidney Int (1994) 0.89

[Surprising results of intravenous therapy using antilymphocyte serum in organ transplantations]. Dtsch Med Wochenschr (1968) 0.88

Influence of chronic UV exposure and lifestyle on facial skin photo-aging--results from a pilot study. J Epidemiol (1999) 0.88

Dominant role of complement in the hyperacute xenograft rejection reaction. Surg Gynecol Obstet (1976) 0.88

Interlocking compression nailing: a report on 402 applications. Arch Orthop Trauma Surg (1998) 0.87

The effects of arteriovenous shunts on cardiac function in renal dialysis patients--an echocardiographic evaluation. Clin Nephrol (1978) 0.87

Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study. Contrib Nephrol (1991) 0.87

Combined report on regular dialysis and transplantation of children in Europe, 1976. Proc Eur Dial Transplant Assoc (1977) 0.87

[Acute compartment syndrome of the lower leg due to knee arthroscopy]. Orthopade (2011) 0.86

The cruciate ligaments in knee replacement. Int Orthop (1989) 0.86

Serum 27E10 antigen: a new potential marker for staging HIV disease. Clin Exp Immunol (1995) 0.86

Induction of tolerance in man to horse-IgG. Lancet (1969) 0.85

Association between borderline personality structure and history of childhood abuse in adult volunteers. Compr Psychiatry (1993) 0.85

[Evaluation of cartilage defects in the knee: validity of clinical, magnetic-resonance-imaging and radiological findings compared with arthroscopy]. Unfallchirurg (2007) 0.85

Degradation mechanism and stability of 5-aminolevulinic acid. J Pharm Sci (2000) 0.85

Ex vivo model of hemodialysis membrane biocompatibility. Trans Am Soc Artif Intern Organs (1985) 0.84

Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients. Transplant Proc (2000) 0.84

Pancreatic duct obstruction with prolamine solution. Transplant Proc (1980) 0.84

[Definition of the Diagnosis Osteomyelitis-Osteomyelitis Diagnosis Score (ODS)]. Z Orthop Unfall (2011) 0.84

Diabetic retinopathy and pancreas transplantation: a 3-year follow-up. Diabetologia (1991) 0.84

Use of three-phase bone scans and SPET in the follow-up of patients with allogenic vascularized femur transplants. Nucl Med Commun (1999) 0.84

[Sustentaculum tali screw placement for calcaneus fractures--different navigation procedures compared to the conventional technique]. Z Orthop Unfall (2010) 0.84

Ciclosporin in renal transplantation. Prog Allergy (1986) 0.84

Metabolic control and effect on secondary complications of diabetes mellitus by pancreatic transplantation. Baillieres Clin Gastroenterol (1989) 0.84

The arterial blood supply of the human patella. Its clinical importance for the operating technique in vascularized knee joint transplantations. Surg Radiol Anat (1997) 0.84

Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines. Transplantation (1996) 0.84

Effect of protein adsorption on diffusive and convective transport through polysulfone membranes. Contrib Nephrol (1985) 0.83

Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes (1993) 0.83

Therapeutic plasmapheresis; present state and future aspects. Life Support Syst (1984) 0.83

Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study. Contrib Nephrol (1989) 0.83

MRP 8/14 as marker for Plasmodium falciparum-induced malaria episodes in individuals in a holoendemic area. Clin Diagn Lab Immunol (1997) 0.83

Transthoracic high frequency (7.5 MHz) echocardiographic assessment of coronary vascular reserve and its relation to left ventricular mass. J Am Coll Cardiol (1990) 0.83

Reactive changes in dorsal roots and dorsal root ganglia after C7 dorsal rhizotomy and ventral root avulsion/replantation in rabbits. J Anat (2007) 0.83

Vascularised knee joint transplantation in man: the first two years experience. Eur J Surg (2000) 0.82

Long-term follow-up of diabetic retinopathy for up to 71 months after combined renal and pancreatic transplantation. Graefes Arch Clin Exp Ophthalmol (1991) 0.82

Cyclosporin in renal transplantation in children. Lancet (1984) 0.82

In vitro studies on the mechanism of hyperacute xenograft rejection. Transplant Proc (1971) 0.82

DiGeorge syndrome with discordant phenotype in monozygotic twins. J Med Genet (2000) 0.82

Allogeneic vascularized grafting of a human knee joint with postoperative immunosuppression. Arch Orthop Trauma Surg (1997) 0.82